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Abstract
Background—Little population-based data exist on limitations and health-related quality of life 
(HRQoL) in adults with congenital heart defects (CHD).
Methods—We used 2004 to 2012 Medical Expenditure Panel Survey data to identify a 
population-based sample of young adults ages 18 to 40 years reporting health symptoms or 
healthcare encounters in the previous year. Comparing adults reporting CHD to others, we 
examined the prevalence of cognitive, physical, and activity limitations, depressive symptoms, and 
physical and mental HRQoL. We used chi square tests to examine differences in demographic 
characteristics, logistic regression to generate adjusted prevalence ratios (aPR), and linear 
regression to examine HRQoL. Multivariable associations were adjusted for sex, age, race/
ethnicity, and smoking status. All analyses were conducted in SUDAAN using weights to account 
for clustering within sampling units and nonresponse.
Results—Fifty-nine adults reported CHD (weighted prevalence=0.1%; representing 700,000 
U.S. adults from 2004 to 2012 or, on average, 80,000 per year) and 54,011 did not. No 
demographic characteristics differed significantly by CHD status except health insurance; 31.5% 
of adults with CHD, compared with 11.0% without, reported public insurance (p=0.01). Compared 
with their counterparts, adults reporting CHD had a higher prevalence of cognitive (aPR=2.7, 95% 
confidence interval (CI): 1.0, 7.2), physical (aPR=4.0, 95% CI: 1.9, 8.2), and activity limitations 
(aPR=4.8, 95% CI: 2.6, 9.1), and poorer physical HRQoL (p=0.004). No differences were 
observed in depressive symptoms and mental HRQoL by CHD status.
Conclusion—Physical health and cognitive abilities of adults with CHD were compromised 
compared with adults without CHD.
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Children with congenital heart defects (CHD), especially the more severe types and those 
requiring surgery, are more likely to experience developmental disabilities, poorer cognitive 
functioning (Karsdorp et al., 2007), and greater physical and activity limitations (Razzaghi 
et al., 2015) than children without CHD, resulting in the need for special education (Riehle-
Colarusso et al., 2015) and occupational, physical, and speech therapies (Marino et al., 
2012). With medical advances, at least 85% of children with CHD now survive to adulthood 
(Moons et al., 2010). However, the physical and cognitive limitations of adults with CHD 
are not well-understood. Depression is also a concern for individuals with CHD, although 
studies disagree on whether the prevalence of depression differs among individuals with and 
without CHD (Kovacs and Moons, 2014; Jackson et al., 2015). Systematic reviews and 
meta-analyses show that the majority of U.S.-based studies on limitations, health-related 
quality of life (HRQoL), and depressive symptoms among adults with CHD are based on 
convenience or clinical samples, with unknown generalizability to the general U.S. adult 
population with CHD (Fteropoulli et al., 2013; Jackson et al., 2015; Kahr et al., 2015). 
Therefore, to inform the healthcare needs of U.S. adults with CHD, we examined physical 
and cognitive limitations, depressive symptoms, and HRQoL among a population-based 
sample of U.S. adults ages 18 to 40 years with healthcare encounters for or symptoms 
attributed to CHD.
Materials and Methods
Using computer-assisted telephone interviewing, the Medical Expenditure Panel Survey 
(MEPS) surveys a subsample of participants in the National Health Interview Survey 
(NHIS), an annual population-based survey of adults (meps.ahrq.gov). When an adult is 
selected for MEPS, he/she is surveyed five times over 2 years and is asked about his/her own 
and his/her household members’ demographic characteristics, income, employment, health 
insurance, health status, and medical care use and expenditures. At each contact, the 
household respondent is asked about his/her own and his/her family members’ physical and 
mental health problems experienced since the previous interview (regardless of whether the 
person sought medical care for the condition). Those reported physical and mental health 
problems are subsequently translated into ICD-9-CM codes by MEPS survey staff. In 
addition, once a year, each household member 18 years and older completes a self-
administered questionnaire on his/her physical and mental health, depressive symptoms, and 
HRQoL. When an individual cannot complete the self-administered questionnaire, a 
household member completes it for him/her. MEPS overall response rate varies over time; 
during the study period of the current analysis, the highest response rate was 63.1% in 2004 
and the lowest was 53.5% in 2010. Each observation is associated with a weight, adjusted 
for nonresponse, to reflect the number of persons in the U.S. population represented by the 
participant.
For this analysis, we examined survey data collected from 2004 to 2012 to describe 
sociodemographic characteristics, cognitive, physical, and activity limitations, depressive 
symptoms, and HRQoL among adults ages 18 to 40 years with healthcare encounters for or 
symptoms of CHD and compared them with all other survey participants in this age group 
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who also reported healthcare encounters or symptoms due to conditions other than CHD. 
Adults over 40 years of age were excluded because many reported heart problems in this age 
category were assumed to be acquired rather than congenital. We compared adults with 
CHD (ICD-9-CM codes 745: bulbus cordis anomalies and anomalies of cardiac septal 
closure; 746: other congenital anomalies of heart; and 747: other congenital anomalies of 
circulatory system) to adults with at least one healthcare encounter or symptom, but no CHD 
reported. MEPS public use data provide only three-digit ICD-9-CM codes. A maximum of 2 
years of data were collected for each individual included in MEPS. MEPS is designed so 
that each year of data is representative of the U.S. population for that year. For variables 
assessed more than once per year (e.g., marital status), we examined data from the first time 
point only.
Sociodemographic variables included age, sex, race/ethnicity, marital status, education, 
household income as a percentage of the federal poverty level (FPL), employment status, 
obesity (body mass index ≥30 kg/m2), smoking status, and relationship to head of household 
(self/spouse or dependent/other). FPL was categorized according to U.S. Census Bureau 
categories as poor (incomes below the FPL), near poor (≥FPL to 125% FPL), low income 
(126–200% FPL), middle income (201–400% FPL), and high income (>400% FPL) (http://
www.census.gov/hhes/www/poverty/data/threshld/index.html).
Cognitive limitations were defined as “confusion or memory loss, had problems making 
decisions, or required supervision for their own safety.” Physical limitations was defined as 
“difficulties walking, climbing stairs, grasping objects, reaching overhead, lifting, bending 
or stooping, or standing for long periods of time.” Activity limitations was defined as 
“limited in any way at work, in the house, or at school.” Depressive symptoms was a 
dichotomous measure (yes/no) based on a sum of ≥3 on the two-item Patient Health 
Questionnaire (PHQ-2), with a sensitivity of 82.9% and specificity of 90.0% for major 
depression (Kroenke et al., 2003). HRQoL was based on the 12-item short form (SF-12) 
survey that assesses separate components of physical health and mental health, resulting in a 
composite score with a range of 0 to 100; a lower score signifies poorer HRQoL (RAND/
Quality Metric).
Age, sex, race/ethnicity, education, FPL, marital status, employment, obesity, smoking 
status, insurance status, and cognitive, physical, and activity limitations are based on the 
household respondent’s answers for the individuals in the sample. General health, depressive 
symptoms, and HRQoL were self-reported by most individuals.
Initially, we examined prevalence of sociodemographic and health characteristics, 
limitations, depressive symptoms, and HRQoL comparing those who did and did not report 
CHD. We examined differences in categorical variables using chi square tests and in 
continuous variables using t-tests. For all outcomes, we assessed differences by age group, 
sex, and inpatient hospitalization in the past year. Using the average marginal predictions 
approach to logistic regression (Bieler et al., 2010), we generated adjusted prevalence ratios 
for general health, cognitive, physical, and activity limitations, and depressive symptoms, 
with CHD status as the exposure of interest. We used linear regression to examine 
differences in summary scores for physical and mental health components of HRQoL. We 
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constructed separate models for each outcome of interest and included age, sex, race/
ethnicity, and smoking status as potential confounders based on previous literature. We 
conducted all analyses using SUDAAN software to account for the complex sampling 
design, and used weights to produce unbiased prevalence estimates that account for 
clustering within sampling units, including family, multiple observations per person, and 
nonresponse. In sensitivity analyses, we also ran models in SAS without weights or 
accounting for sample design.
Results
Between 2004 and 2012, MEPS data were collected on 96,297 adults ages 18 to 40. Of 
these, 66,680 (69.2%) reported one or more healthcare encounters or symptoms and were 
eligible to complete the self-administered questionnaire. Of those, 62,553 (93.8%) 
completed the self-administered questionnaire and 54,070 (81.1% of eligible) had data on all 
variables of interest. Among this sample, 59 reported a healthcare encounter or symptom of 
CHD (weighted, this represents over 700,000 U.S. adults with CHD from 2004 to 2012, on 
average, 80,000 per year, or a “treated prevalence” of CHD of 0.1%) and 54,011 reported a 
healthcare encounter or symptom for a condition other than CHD. None of the adults 
reporting CHD also reported Down syndrome (ICD-9-CM code 748), nor did any report 
more than one three-digit ICD-9-CM code for CHD (e.g., both 745 and 746). Additionally, 
15.3% of individuals with CHD and 7.5% of individuals without had a household proxy 
complete the self-administered questionnaire for them (chi square p-value = 0.04).
The majority (60.9%) of adults with CHD in our sample reported an ICD-9-CM code of 745 
(Table 1). Point prevalence estimates for age group, race/ethnicity, education, and 
relationship to head of household varied by over 10 percentage points with CHD status; 
however, confidence intervals for the CHD group were wide and only one statistically 
significant difference in sociodemographic characteristics was found. Of individuals with 
CHD, 31.5% had public health insurance, compared with 11.0% of those without CHD (p = 
0.01). A lower percentage of individuals with CHD, compared with those without CHD, 
were 34 to 40 years of age (19.7% and 32.4%), Hispanic or other race/ethnicity (9.2% and 
22.8%), and the head of household or spouse (56.3% and 79.7%) (p >0.05 for all). 
Additionally, 36.9% of individuals with CHD, compared with 16.2% of those without, had 
<a high school education (p >0.05).
General health, physical, cognitive, and activity limitations, and physical HRQoL differed 
by CHD status, while depressive symptoms and mental HRQoL did not (Table 2). The 
majority of adults with and without CHD, respectively, reported excellent (13.4% and 
23.2%) or very good (49.3% and 40.8%) health (p = 0.5). After adjusting for confounders, 
individuals with CHD were almost twice as likely to report fair or poor general health as 
individuals without CHD. In multivariable models, adults with CHD had 2.7 times the 
prevalence of cognitive limitations, 4.0 times the prevalence of physical limitations, and 4.8 
times the prevalence of activity limitations as adults without CHD. Adults with CHD, 
compared with those without, were also more likely to report poorer physical HRQoL (p = 
0.004). When running the same multivariable models without weights and not accounting 
for sampling design, point estimates were of the same magnitude and direction, but 95% CIs 
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were slightly more precise. Among adults with CHD, we found no difference in general 
health, limitations, or depressive symptoms by sex, age, ICD-9 code, or past-year 
hospitalization (chi-square p-value >0.05 for all).
Discussion
Within this population-based sample of U.S. adults aged 18 to 40 years, 0.1% (representing 
700,000 U.S. adults from 2004 to 2012 or, on average, 80,000 per year) reported receiving 
care specifically for CHD or experiencing symptoms attributed to CHD in the year surveyed. 
Approximately a third of adults with CHD reported <a high school education, 30% reported 
having public insurance, and half were considered dependents in the household. After 
adjusting for confounders, adults with CHD were more likely to have fair or poor general 
health; cognitive and physical limitations; limitations affecting work, home, or school; and 
poorer physical HRQoL than adults without CHD. We found no differences in depressive 
symptoms or mental HRQoL by CHD status.
Our findings on general health, physical and cognitive limitations are similar to two recent 
systematic reviews which included 31 studies (Fteropoulli et al., 2013) and 5 studies (Tyagi 
et al., 2014) among adults with CHD. The majority of studies included in the first review 
found poorer self-perceived general health and poorer physical functioning among adults 
with CHD compared with the general adult population. The authors reported younger age, 
female gender, disease severity, and arrhythmias as risk factors for poorer physical HRQoL. 
In our analysis of young adults with CHD, we found no significant differences in physical 
limitations by age or sex, but power was limited. Unlike our analysis, which found a higher 
prevalence of limitations at work, home, or school, only a minority of studies included in the 
systematic review reported more disability in work and daily activities. The second 
systematic review on cognitive functioning reported that two out of four studies found lower 
intelligence quotient scores and a fifth study found impaired executive functioning in adults 
with CHD (Tyagi et al., 2014). The discrepancies between this study and ones included in 
the review may be due to differences in type and severity of CHD as well as age of adults 
and country where conducted.
Approximately 37% of adults with CHD had less than a high school education, although this 
estimate had wide confidence intervals and did not differ statistically from that among adults 
without CHD (16%). However, no meaningful differences in employment or FPL were seen 
by CHD status. Others have found lower educational attainment and employment rates 
among individuals with CHD compared with their counterparts (Kamphuis et al., 2002; 
Olsen et al., 2011). Additionally, studies among children have found a larger percentage of 
children with specific types of CHD and with surgical repair for CHD with adverse 
neurodevelopmental outcomes, lower academic achievement, and a greater need for special 
education services compared with children without CHD (Razzaghi et al., 2015; Riehle-
Colarusso et al., 2015). Within MEPS data, we were unable to discern type of employment 
and, with 44% of adults with CHD living as a dependent in the household, the measure of 
FPL may reflect the individual’s parents’ income. Larger U.S. studies are needed to 
determine whether the differences in cognitive function seen in childhood have long-term 
financial and social implications in adulthood.
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To our knowledge, this is one of the first U.S. population-based analyses of adults with 
healthcare encounters for or symptoms of CHD. We were able to examine key 
socioeconomic variables such as education, employment, and insurance status, in addition to 
cognitive, physical, and activity limitations, depressive symptoms, and HRQoL data that are 
typically unavailable in hospital, surgical, and administrative databases. However, this 
analysis is also subject to several limitations. First, health conditions, such as CHD, were 
reported by a household respondent who may be unaware of all symptoms experienced by 
individuals in his or her household.
Second, our results are generalizable only to individuals with healthcare encounters for or 
symptoms of CHD and may overestimate associations if generalized to the entire adult 
population with CHD. Our estimate of a treated prevalence of CHD of 0.1% is lower than 
the estimated prevalence of CHD in the general adult population (Hoffman et al., 2004; 
Marelli et al., 2007). This is likely due to under-reporting by the respondent, asymptomatic 
CHD that did not result in a healthcare encounter during the surveyed year, and CHD-related 
symptoms not attributed to CHD (e.g., shortness of breath or edema). Therefore, the adults 
reporting CHD in our analysis may have more severe CHD than the general U.S. population 
of adults with CHD because these data are limited to those with symptoms attributable to 
CHD and/or who sought healthcare for CHD.
Additionally, five-digit ICD-9-CM codes are not available in the MEPS public use data and 
may also be limited by the specificity of the self-report, precluding an assessment of 
associations by type of CHD. MEPS response rates are between 54% and 63% for the years 
included, although estimates are weighted for nonresponse and comparable to other national 
surveys. In addition, we excluded 6% of adults for not completing the self-administered 
questionnaire and another 12% for missing data. Lastly, because the sample size of 
individuals reporting healthcare encounters or symptoms of CHD was small (n = 59) our 
estimates are imprecise.
Overall, we found that young adults with healthcare encounters for or symptoms of CHD 
were almost two to four times more likely to report fair or poor general health; cognitive, 
physical, and activity limitations; and poorer physical HRQoL than adults without CHD. 
Novel methods of surveillance are needed to identify adult CHD survivors in the general 
population and understand their unique healthcare needs and outcomes. Information gained 
will help parents of children born with CHD plan for the future, current adults with CHD, 
along with their clinicians, make evidence-based decisions about their health, and 
policymakers ensure adequate resources are available for the growing population of adults 
with CHD.
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TABLE 1
Characteristics of Adults Ages 18–40 Years with and without Health Care Encounters for or Symptoms of 
Congenital Heart Defects (CHD),a Medical Expenditure Panel Survey, 2004 to 2012
Healthcare encounters for or symptoms of CHD
p-Valuec
Yes N = 59
Weighted %, 95% CI
Nob N = 54,619
Weighted %, 95% CI
ICD-9-CM code
 745 60.6 (37.1, 80.1) n/a
 746 17.9 (8.0, 35.2)
 747 21.5 (8.5, 44.7)
Sex 0.79
Female 50.9 (26.6, 74.7) 54.5 (53.9, 55.1)
Male 49.1 (25.3, 73.4) 45.5 (44.9, 46.1)
Age (years) 0.41
18–25 37.3 (19.2, 59.9) 31.4 (30.6, 32.1)
26–33 43.0 (26.2, 61.5) 36.3 (35.5, 37.1)
34–40 19.7 (7.8, 41.5) 32.4 (31.6, 33.1)
Race/ethnicity 0.08
Hispanic/other 9.2 (3.5, 22.2) 22.8 (21.5, 24.1)
Black, non-Hispanic 9.9 (4.4, 20.7) 11.4 (10.6, 12.3)
White, non-Hispanic 80.9 (68.3, 89.3) 65.9 (64.5, 67.2)
Marital status 0.98
Married 42.8 (21.6, 67.0) 42.3 (41.4, 43.3)
Unmarried 57.2 (33.0, 78.4) 57.7 (56.7, 58.6)
Education (years) 0.29
<12 36.9 (14.7, 66.5) 16.2 (15.5, 16.8)
12 20.7 (9.0, 40.9) 43.3 (42.4, 44.2)
>12 37.2 (17.9, 61.6) 34.9 (33.8, 36.0)
Missing 5.2 (1.5, 17.1) 5.7 (5.4, 6.0)
Federal poverty level 0.71
Poor/near poor 13.2 (7.1, 23.3) 17.9 (17.2, 18.6)
Low 13.6 (7.4, 23.7) 13.5 (13.0, 14.0)
Middle 33.6 (17.3, 55.0) 33.2 (32.5, 33.9)
High 39.6 (24.2, 57.5) 35.4 (34.4, 36.4)
Employment status 0.54
Employed/fulltime studentd 78.1 (66.7, 86.4) 81.2 (80.6, 81.7)
Unemployed 21.9 (13.6, 33.3) 18.8 (18.3, 19.4)
Smoking 0.29
Yes 14.1 (5.5, 31.4) 21.7 (21.0, 22.5)
No 86.0 (68.6, 94.5) 78.3 (77.5, 79.0)
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Healthcare encounters for or symptoms of CHD
p-Valuec
Yes N = 59
Weighted %, 95% CI
Nob N = 54,619
Weighted %, 95% CI
Obese (BMI ≥30 kg/m2) 0.47
Yes 20.1 (9.0, 39.1) 26.1 (25.4, 26.8)
No 79.9 (61.0, 91.0) 73.9 (73.2, 74.6)
Insurance status 0.01
Private 65.4 (35.0, 86.9) 72.0 (71.1, 72.9)
Public 31.5 (10.9, 63.3) 11.0 (10.4, 11.6)
Uninsured 3.1 (0.5, 16.0) 17.0 (16.4, 17.7)
Relationship to head of household 0.19
Self/spouse 56.3 (29.8, 79.7) 79.7 (78.9, 80.4)
Other 43.7 (20.4, 70.2) 20.3 (19.6, 21.1)
a
Defined as ICD-9-CM codes 745, 746, 747; a condition is reported if the individual received care for it or it “bothered” the person in the past year. 
All variables based on the household respondent report.
b
Among individuals with ≥1 healthcare encounters or symptomatic health conditions other than CHD.
c
Chi square p-value for categorical variables; t-test p-value for means.
d
Fulltime student status assessed for individuals ages 18–23 years.
BMI, body mass index; CHD, congenital heart defect; CI, confidence interval; ICD-9-CM, The International Classification of Diseases, Ninth 
Revision, Clinical Modification.
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